Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenu archivé le 2024-05-27

AmylolEnzymes Captured by Targeted Metagenomics

Objectif

The aim of the AMYLOMICS project is to develop novel, robust enzymes for the starch and carbohydrate industries. The novel enzymes should enable the formation of new primary products, such as oligosaccharides of defined sizes, composition and degree of branching, new types of linkages, cyclic or more complex polysaccharides and an increased digestive resistance, as well as secondary sugar derivatives such as substituted starches, rare sugars or novel isomers.

Fundamental to the success of the project will be the development of an efficient metagenomic platform technology for enzyme screening based on massive parallel 454 sequencing and microarray sequence capture. This platform will enable “genome walking” of complex metagenomic DNA and greatly facilitate the access to the largely unexplored wealth of genes in the environment.

The starch industry is the most developed sector of the polysaccharide industry and European companies play a leading role in the world market. The industry is in a constant need for a range of robust enzymes that can be used for the synthesis, fractionation and/or modification of carbohydrates. It actively searches for sustainable and more economical alternatives to existing techniques, both for the production of novel higher value products and for the improvement of older processes. The metagenomic mining platform developed in the project is expected to provide a large number of robust thermophilic starch and carbohydrate modifying enzymes and lead to new and improved biocatalytic process technologies.
Lead users of the project’s results will be companies like the project partners Roquette Frères, a world leader in starch processing, Roche Molecular Systems, a leading providers of new tools, technologies and services in the genomic industry, and SME companies like Prokazyme who through the improvement of sequence based metagenomic bioprospecting platform can expand their product range of speciality products.

Appel à propositions

FP7-KBBE-2010-4
Voir d’autres projets de cet appel

Coordinateur

MATIS OHF
Contribution de l’UE
€ 638 546,00
Adresse
VINLANDSLEID 12
113 Reykjavik
Islande

Voir sur la carte

Région
Ísland Ísland Höfuðborgarsvæði
Type d’activité
Research Organisations
Contact administratif
Gudmundur Oli Hreggvidsson (Dr.)
Liens
Coût total
Aucune donnée

Participants (8)